ATE420115T1 - Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs - Google Patents
Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebsInfo
- Publication number
- ATE420115T1 ATE420115T1 AT03760023T AT03760023T ATE420115T1 AT E420115 T1 ATE420115 T1 AT E420115T1 AT 03760023 T AT03760023 T AT 03760023T AT 03760023 T AT03760023 T AT 03760023T AT E420115 T1 ATE420115 T1 AT E420115T1
- Authority
- AT
- Austria
- Prior art keywords
- mab
- monoclonal antibody
- aurora
- optionally
- diagnosing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207212A FR2840905B1 (fr) | 2002-06-12 | 2002-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420115T1 true ATE420115T1 (de) | 2009-01-15 |
Family
ID=29595167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03760023T ATE420115T1 (de) | 2002-06-12 | 2003-06-12 | Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7514231B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1511771B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4555681B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE420115T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003255671A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2489214C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60325725D1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2840905B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003106500A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7572914B2 (en) | 2003-12-19 | 2009-08-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2006023931A2 (en) | 2004-08-18 | 2006-03-02 | Takeda San Diego, Inc. | Kinase inhibitors |
| EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| JP2010505962A (ja) | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3944241B2 (ja) * | 1995-12-18 | 2007-07-11 | スージェン・インコーポレーテッド | Aur―1および/またはaur―2関連疾患の診断および処置 |
-
2002
- 2002-06-12 FR FR0207212A patent/FR2840905B1/fr not_active Expired - Lifetime
-
2003
- 2003-06-12 US US10/517,645 patent/US7514231B2/en not_active Expired - Lifetime
- 2003-06-12 EP EP03760023A patent/EP1511771B1/fr not_active Expired - Lifetime
- 2003-06-12 AU AU2003255671A patent/AU2003255671A1/en not_active Abandoned
- 2003-06-12 AT AT03760023T patent/ATE420115T1/de not_active IP Right Cessation
- 2003-06-12 JP JP2004513330A patent/JP4555681B2/ja not_active Expired - Lifetime
- 2003-06-12 DE DE60325725T patent/DE60325725D1/de not_active Expired - Lifetime
- 2003-06-12 WO PCT/FR2003/001772 patent/WO2003106500A1/fr not_active Ceased
- 2003-06-12 CA CA2489214A patent/CA2489214C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003255671A8 (en) | 2003-12-31 |
| JP2006513135A (ja) | 2006-04-20 |
| AU2003255671A1 (en) | 2003-12-31 |
| US20070117163A1 (en) | 2007-05-24 |
| CA2489214A1 (fr) | 2003-12-24 |
| FR2840905A1 (fr) | 2003-12-19 |
| DE60325725D1 (de) | 2009-02-26 |
| FR2840905B1 (fr) | 2006-07-07 |
| CA2489214C (fr) | 2013-08-06 |
| EP1511771B1 (fr) | 2009-01-07 |
| WO2003106500A1 (fr) | 2003-12-24 |
| EP1511771A1 (fr) | 2005-03-09 |
| JP4555681B2 (ja) | 2010-10-06 |
| US7514231B2 (en) | 2009-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grünewald et al. | Ewing sarcoma | |
| Knittel et al. | Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-) fibroblast subpopulations in hepatic tissue repair | |
| ATE538809T1 (de) | Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| DE69717664D1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| ATE419516T1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| RU2007141067A (ru) | Терапия с помощью антител к egfr, основанная на повышенном числе копий гена egfr в опухолевых тканях | |
| DE60239059D1 (de) | Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums beingen einer antiöstrogen-therapie resistent sind | |
| WO2014197937A1 (en) | Methods for detecting prostate cancer | |
| Ratkaj et al. | Microarray analysis of Dupuytren’s disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway | |
| Mak et al. | Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells | |
| ATE447715T1 (de) | Automatische glykofingerabdruck-strategie | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| Larsen et al. | Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma | |
| CN1928563A (zh) | 乳腺癌的免疫组化诊断试剂盒和测试片 | |
| DE602005019694D1 (de) | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose | |
| DE60325725D1 (de) | Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs | |
| RU2007141930A (ru) | Способ in vitro идентификации соединений для лечения рака | |
| IL190401A0 (en) | Antibodies against april as biomarkers for early prognosis of lymphoma patients | |
| FR2919061B1 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal. | |
| WO2003068268A3 (en) | Treatment, diagnosis and imaging of disease | |
| DE60221115D1 (de) | Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose | |
| WO2004040312A3 (fr) | Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie | |
| EA200802356A1 (ru) | Способ выявления и диагностики злокачественного новообразования, включающий праймеры и зонды для специфичного выявления маркера mage-a3 | |
| Vercelli et al. | Expression of transforming growth factor‐β isoforms in the skin, kidney, pancreas and bladder in a German shepherd dog affected by renal cystadenocarcinoma and nodular dermatofibrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |